| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Periodontitis | 92 | 2024 | 552 | 16.950 |
Why?
|
| Chronic Periodontitis | 21 | 2022 | 101 | 5.210 |
Why?
|
| Eicosapentaenoic Acid | 25 | 2022 | 581 | 4.920 |
Why?
|
| Periodontal Diseases | 20 | 2023 | 447 | 4.850 |
Why?
|
| Lipoxins | 22 | 2022 | 412 | 4.180 |
Why?
|
| Gingivitis | 13 | 2021 | 123 | 3.450 |
Why?
|
| Inflammation Mediators | 30 | 2023 | 1888 | 3.200 |
Why?
|
| Neutrophils | 42 | 2021 | 3718 | 3.150 |
Why?
|
| Inflammation | 57 | 2024 | 10629 | 2.860 |
Why?
|
| Docosahexaenoic Acids | 16 | 2023 | 877 | 2.140 |
Why?
|
| Porphyromonas gingivalis | 19 | 2021 | 169 | 2.090 |
Why?
|
| Aggressive Periodontitis | 6 | 2015 | 59 | 1.530 |
Why?
|
| Superoxides | 11 | 2015 | 387 | 1.510 |
Why?
|
| Periodontal Ligament | 10 | 2022 | 118 | 1.490 |
Why?
|
| Dental Plaque | 14 | 2018 | 205 | 1.420 |
Why?
|
| Anti-Inflammatory Agents | 14 | 2022 | 1789 | 1.420 |
Why?
|
| Fatty Acids, Omega-3 | 7 | 2023 | 1344 | 1.370 |
Why?
|
| Dental Scaling | 18 | 2022 | 102 | 1.350 |
Why?
|
| Eicosanoids | 8 | 2024 | 279 | 1.340 |
Why?
|
| Alveolar Bone Loss | 18 | 2023 | 362 | 1.220 |
Why?
|
| Bone Substitutes | 5 | 2014 | 216 | 1.190 |
Why?
|
| Dental Implants | 7 | 2021 | 684 | 1.080 |
Why?
|
| Diacylglycerol Kinase | 5 | 2013 | 48 | 1.080 |
Why?
|
| Guided Tissue Regeneration, Periodontal | 4 | 2015 | 138 | 1.070 |
Why?
|
| Gingival Crevicular Fluid | 12 | 2021 | 93 | 1.060 |
Why?
|
| Epoxide Hydrolases | 2 | 2024 | 122 | 1.060 |
Why?
|
| Root Planing | 9 | 2022 | 68 | 0.990 |
Why?
|
| Peri-Implantitis | 3 | 2018 | 90 | 0.980 |
Why?
|
| Bone Regeneration | 6 | 2018 | 420 | 0.960 |
Why?
|
| Periodontal Index | 18 | 2022 | 144 | 0.940 |
Why?
|
| Diabetes Complications | 5 | 2014 | 1360 | 0.930 |
Why?
|
| Periodontal Pocket | 17 | 2020 | 166 | 0.910 |
Why?
|
| Diabetes Mellitus, Type 2 | 13 | 2021 | 11729 | 0.900 |
Why?
|
| Polyanhydrides | 2 | 2014 | 5 | 0.880 |
Why?
|
| Calcium Hydroxide | 2 | 2014 | 16 | 0.880 |
Why?
|
| Group VI Phospholipases A2 | 2 | 2014 | 14 | 0.880 |
Why?
|
| Bone Resorption | 6 | 2024 | 722 | 0.870 |
Why?
|
| Periodontal Attachment Loss | 15 | 2020 | 139 | 0.840 |
Why?
|
| Polymethyl Methacrylate | 3 | 2016 | 145 | 0.840 |
Why?
|
| Fatty Acids, Unsaturated | 4 | 2023 | 546 | 0.830 |
Why?
|
| Cytokines | 20 | 2023 | 7324 | 0.810 |
Why?
|
| Periodontics | 4 | 2020 | 43 | 0.810 |
Why?
|
| Receptors, Leukotriene B4 | 3 | 2023 | 94 | 0.810 |
Why?
|
| Chemotaxis, Leukocyte | 8 | 2011 | 675 | 0.800 |
Why?
|
| Osteogenesis | 11 | 2023 | 1291 | 0.800 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 2 | 2017 | 32 | 0.770 |
Why?
|
| Phagocytosis | 9 | 2016 | 1539 | 0.770 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 10 | 2011 | 222 | 0.760 |
Why?
|
| Monocytes | 10 | 2017 | 2593 | 0.760 |
Why?
|
| Bacteroidaceae Infections | 6 | 2014 | 32 | 0.720 |
Why?
|
| Cleft Lip | 2 | 2022 | 478 | 0.710 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 7 | 2011 | 2281 | 0.710 |
Why?
|
| Amnion | 1 | 2021 | 209 | 0.700 |
Why?
|
| Dental Plaque Index | 11 | 2021 | 84 | 0.630 |
Why?
|
| Animals | 77 | 2024 | 168660 | 0.630 |
Why?
|
| Rabbits | 9 | 2022 | 4894 | 0.620 |
Why?
|
| X-Ray Microtomography | 8 | 2024 | 428 | 0.610 |
Why?
|
| Osteoclasts | 9 | 2018 | 729 | 0.600 |
Why?
|
| Cytochrome Reductases | 1 | 2016 | 9 | 0.590 |
Why?
|
| Focal Infection, Dental | 3 | 2007 | 24 | 0.590 |
Why?
|
| Bone and Bones | 4 | 2018 | 2576 | 0.580 |
Why?
|
| Polyhydroxyethyl Methacrylate | 2 | 2014 | 31 | 0.580 |
Why?
|
| Propolis | 1 | 2016 | 14 | 0.570 |
Why?
|
| Diabetes Mellitus | 9 | 2023 | 5752 | 0.560 |
Why?
|
| Bacteria | 7 | 2019 | 2112 | 0.560 |
Why?
|
| Alveolar Process | 6 | 2014 | 286 | 0.550 |
Why?
|
| Humans | 173 | 2024 | 743811 | 0.540 |
Why?
|
| Tooth Socket | 2 | 2014 | 115 | 0.530 |
Why?
|
| Lipopolysaccharides | 11 | 2023 | 2217 | 0.520 |
Why?
|
| Diet, Atherogenic | 1 | 2015 | 96 | 0.520 |
Why?
|
| Periodontium | 5 | 2021 | 94 | 0.520 |
Why?
|
| Receptors, Chemokine | 4 | 2012 | 670 | 0.510 |
Why?
|
| Wound Healing | 7 | 2022 | 2776 | 0.500 |
Why?
|
| Mouthwashes | 3 | 2005 | 57 | 0.500 |
Why?
|
| Matrix Metalloproteinase 8 | 2 | 2011 | 56 | 0.500 |
Why?
|
| Stomatitis | 2 | 2015 | 267 | 0.490 |
Why?
|
| Dentition | 1 | 2013 | 20 | 0.480 |
Why?
|
| Dental Enamel Proteins | 2 | 2011 | 35 | 0.470 |
Why?
|
| C-Reactive Protein | 10 | 2015 | 3778 | 0.470 |
Why?
|
| Cardiovascular Diseases | 9 | 2021 | 15142 | 0.460 |
Why?
|
| Dental Research | 2 | 2005 | 58 | 0.460 |
Why?
|
| Glucose Intolerance | 1 | 2017 | 577 | 0.450 |
Why?
|
| Dental Abutments | 1 | 2013 | 88 | 0.440 |
Why?
|
| Fibrinogen | 2 | 2013 | 894 | 0.440 |
Why?
|
| Alveolar Ridge Augmentation | 3 | 2014 | 187 | 0.430 |
Why?
|
| Biofilms | 7 | 2016 | 615 | 0.430 |
Why?
|
| Mouth Diseases | 1 | 2015 | 241 | 0.430 |
Why?
|
| Myeloid Cells | 1 | 2017 | 808 | 0.430 |
Why?
|
| Interleukin-1 | 4 | 2005 | 1263 | 0.430 |
Why?
|
| Host-Pathogen Interactions | 5 | 2016 | 1479 | 0.430 |
Why?
|
| Hyperglycemia | 4 | 2015 | 1373 | 0.430 |
Why?
|
| RNA Precursors | 1 | 2013 | 209 | 0.430 |
Why?
|
| Peritonitis | 2 | 2012 | 365 | 0.420 |
Why?
|
| Titanium | 2 | 2021 | 487 | 0.410 |
Why?
|
| Immunity, Active | 2 | 2008 | 60 | 0.410 |
Why?
|
| Disease Models, Animal | 17 | 2022 | 18027 | 0.410 |
Why?
|
| Anti-Infective Agents | 3 | 2016 | 971 | 0.410 |
Why?
|
| Atherosclerosis | 5 | 2017 | 3445 | 0.410 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2022 | 3510 | 0.410 |
Why?
|
| Leukocytes | 7 | 2015 | 2044 | 0.400 |
Why?
|
| Membranes, Artificial | 2 | 2010 | 371 | 0.400 |
Why?
|
| Swine, Miniature | 4 | 2015 | 961 | 0.400 |
Why?
|
| Lipid Metabolism | 5 | 2017 | 1885 | 0.390 |
Why?
|
| Dental Prosthesis Retention | 1 | 2011 | 31 | 0.390 |
Why?
|
| Oral Hygiene | 3 | 2010 | 125 | 0.390 |
Why?
|
| Gingival Hemorrhage | 5 | 2014 | 49 | 0.380 |
Why?
|
| Giant Cells, Foreign-Body | 1 | 2010 | 10 | 0.380 |
Why?
|
| Male | 92 | 2023 | 349776 | 0.370 |
Why?
|
| Macrophages | 7 | 2023 | 5651 | 0.370 |
Why?
|
| Neutrophil Infiltration | 4 | 2023 | 390 | 0.370 |
Why?
|
| Furcation Defects | 2 | 2009 | 36 | 0.370 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2020 | 1632 | 0.350 |
Why?
|
| Maxillary Sinus | 1 | 2011 | 156 | 0.350 |
Why?
|
| HL-60 Cells | 5 | 2013 | 365 | 0.350 |
Why?
|
| Fibroblasts | 4 | 2022 | 4162 | 0.350 |
Why?
|
| Ceruloplasmin | 1 | 2009 | 55 | 0.350 |
Why?
|
| Gingiva | 3 | 2015 | 380 | 0.350 |
Why?
|
| Nanostructures | 1 | 2014 | 552 | 0.350 |
Why?
|
| Lipids | 3 | 2018 | 3307 | 0.340 |
Why?
|
| Arteriosclerosis | 2 | 2004 | 1092 | 0.340 |
Why?
|
| Homeostasis | 6 | 2013 | 3337 | 0.340 |
Why?
|
| Carotid Arteries | 1 | 2013 | 949 | 0.340 |
Why?
|
| Zymosan | 5 | 2011 | 124 | 0.340 |
Why?
|
| Administration, Topical | 3 | 2021 | 689 | 0.340 |
Why?
|
| Random Allocation | 4 | 2015 | 2429 | 0.330 |
Why?
|
| Mandibular Diseases | 1 | 2009 | 118 | 0.330 |
Why?
|
| Interleukin-1beta | 8 | 2015 | 973 | 0.330 |
Why?
|
| Apoptosis | 5 | 2017 | 9718 | 0.330 |
Why?
|
| Gingivoplasty | 1 | 2008 | 30 | 0.330 |
Why?
|
| Oral Surgical Procedures | 3 | 2012 | 167 | 0.320 |
Why?
|
| Immunity, Innate | 6 | 2018 | 2961 | 0.320 |
Why?
|
| Alternative Splicing | 1 | 2013 | 1117 | 0.320 |
Why?
|
| Disease Susceptibility | 6 | 2015 | 1781 | 0.320 |
Why?
|
| Cells, Cultured | 18 | 2021 | 19232 | 0.320 |
Why?
|
| Intracellular Fluid | 2 | 2005 | 203 | 0.310 |
Why?
|
| Respiratory Burst | 1 | 2008 | 114 | 0.310 |
Why?
|
| Hydroxyapatites | 1 | 2007 | 74 | 0.310 |
Why?
|
| Saliva | 5 | 2013 | 809 | 0.310 |
Why?
|
| DNA, Bacterial | 4 | 2012 | 1463 | 0.310 |
Why?
|
| Models, Biological | 4 | 2020 | 9582 | 0.300 |
Why?
|
| Adult | 54 | 2021 | 213889 | 0.300 |
Why?
|
| Carotid Artery Diseases | 1 | 2013 | 875 | 0.300 |
Why?
|
| Mice | 27 | 2024 | 81154 | 0.290 |
Why?
|
| RANK Ligand | 5 | 2018 | 325 | 0.290 |
Why?
|
| Receptors, Immunologic | 4 | 2008 | 1423 | 0.290 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 4 | 2008 | 697 | 0.290 |
Why?
|
| Calcium Phosphates | 1 | 2007 | 170 | 0.280 |
Why?
|
| Neutrophil Activation | 6 | 2009 | 186 | 0.280 |
Why?
|
| Calcium | 5 | 2010 | 5755 | 0.280 |
Why?
|
| Rats, Wistar | 8 | 2023 | 1892 | 0.280 |
Why?
|
| Female | 73 | 2021 | 380020 | 0.280 |
Why?
|
| Up-Regulation | 5 | 2013 | 4221 | 0.280 |
Why?
|
| Ibuprofen | 2 | 2005 | 236 | 0.280 |
Why?
|
| Oxycodone | 2 | 2005 | 153 | 0.280 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 6 | 2014 | 489 | 0.270 |
Why?
|
| Minocycline | 3 | 2014 | 163 | 0.270 |
Why?
|
| Interleukin-10 | 4 | 2012 | 1200 | 0.270 |
Why?
|
| Aspirin | 6 | 2020 | 3283 | 0.270 |
Why?
|
| Cicatrix | 2 | 2022 | 763 | 0.270 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 1836 | 0.260 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 5 | 2014 | 480 | 0.260 |
Why?
|
| Cimetidine | 1 | 2005 | 78 | 0.260 |
Why?
|
| RNA, Messenger | 6 | 2014 | 13028 | 0.260 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2005 | 38 | 0.260 |
Why?
|
| Surface Properties | 3 | 2014 | 1168 | 0.260 |
Why?
|
| Osteolysis | 2 | 2018 | 270 | 0.260 |
Why?
|
| Biocompatible Materials | 1 | 2014 | 1731 | 0.260 |
Why?
|
| Case-Control Studies | 13 | 2017 | 21733 | 0.260 |
Why?
|
| Fusobacterium nucleatum | 2 | 2016 | 163 | 0.260 |
Why?
|
| Bacterial Infections | 1 | 2013 | 1400 | 0.260 |
Why?
|
| Interleukin-8 | 2 | 2005 | 690 | 0.260 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 4 | 2011 | 226 | 0.250 |
Why?
|
| Fibromatosis, Gingival | 1 | 2004 | 7 | 0.250 |
Why?
|
| Platelet-Rich Plasma | 1 | 2007 | 172 | 0.250 |
Why?
|
| Tooth Extraction | 2 | 2006 | 211 | 0.240 |
Why?
|
| Immunologic Factors | 2 | 2012 | 1580 | 0.240 |
Why?
|
| Oxidative Stress | 4 | 2010 | 3082 | 0.240 |
Why?
|
| Models, Animal | 4 | 2021 | 2172 | 0.240 |
Why?
|
| Arachidonic Acid | 1 | 2005 | 434 | 0.240 |
Why?
|
| Adaptive Immunity | 3 | 2014 | 715 | 0.240 |
Why?
|
| Muramidase | 3 | 2010 | 174 | 0.230 |
Why?
|
| Chemotaxis | 2 | 2016 | 607 | 0.230 |
Why?
|
| Swine | 4 | 2015 | 5909 | 0.230 |
Why?
|
| Leukotriene B4 | 4 | 2011 | 294 | 0.230 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2003 | 85 | 0.230 |
Why?
|
| Signal Transduction | 12 | 2018 | 23398 | 0.230 |
Why?
|
| Tumor Necrosis Factor-alpha | 8 | 2018 | 4422 | 0.230 |
Why?
|
| Phosphorylation | 11 | 2019 | 8436 | 0.220 |
Why?
|
| Adjuvants, Immunologic | 3 | 2005 | 999 | 0.220 |
Why?
|
| Middle Aged | 41 | 2021 | 213241 | 0.220 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2006 | 623 | 0.220 |
Why?
|
| Cyclooxygenase 2 | 2 | 2022 | 612 | 0.220 |
Why?
|
| Granulocytes | 1 | 2005 | 548 | 0.220 |
Why?
|
| Metronidazole | 7 | 2014 | 217 | 0.220 |
Why?
|
| Complement C4b | 1 | 2023 | 135 | 0.210 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 2022 | 148 | 0.210 |
Why?
|
| Dinoprostone | 4 | 2013 | 601 | 0.210 |
Why?
|
| Cell Differentiation | 8 | 2021 | 11478 | 0.210 |
Why?
|
| Angiopoietins | 1 | 2022 | 80 | 0.210 |
Why?
|
| Blood Proteins | 1 | 2007 | 1125 | 0.210 |
Why?
|
| Calcification, Physiologic | 2 | 2014 | 169 | 0.200 |
Why?
|
| Coronary Artery Disease | 6 | 2013 | 6485 | 0.200 |
Why?
|
| Spain | 2 | 2013 | 464 | 0.200 |
Why?
|
| Immediate Dental Implant Loading | 2 | 2014 | 56 | 0.200 |
Why?
|
| Osteoprotegerin | 3 | 2018 | 176 | 0.200 |
Why?
|
| Cytoplasm | 2 | 2007 | 1536 | 0.200 |
Why?
|
| Periapical Periodontitis | 2 | 2019 | 30 | 0.200 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2003 | 657 | 0.200 |
Why?
|
| Phagocytes | 2 | 2013 | 296 | 0.200 |
Why?
|
| Histidine | 1 | 2002 | 312 | 0.190 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2015 | 1678 | 0.190 |
Why?
|
| Osseointegration | 2 | 2014 | 262 | 0.190 |
Why?
|
| Chronic Disease | 9 | 2008 | 9139 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2019 | 3338 | 0.190 |
Why?
|
| Receptors, Adiponectin | 1 | 2020 | 82 | 0.190 |
Why?
|
| Receptors, Formyl Peptide | 2 | 2015 | 145 | 0.190 |
Why?
|
| Isoenzymes | 5 | 2013 | 1728 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 12 | 2014 | 7172 | 0.190 |
Why?
|
| Chromatography, Liquid | 2 | 2016 | 975 | 0.190 |
Why?
|
| Endothelium, Vascular | 4 | 2007 | 4459 | 0.190 |
Why?
|
| Double-Blind Method | 10 | 2020 | 12020 | 0.180 |
Why?
|
| Mice, Transgenic | 6 | 2017 | 9731 | 0.180 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2013 | 960 | 0.180 |
Why?
|
| Phosphoproteins | 2 | 2019 | 2440 | 0.180 |
Why?
|
| Ki-67 Antigen | 1 | 2022 | 644 | 0.180 |
Why?
|
| Diglycerides | 3 | 2007 | 176 | 0.180 |
Why?
|
| Consensus | 6 | 2018 | 2954 | 0.180 |
Why?
|
| Cytochromes c | 2 | 2011 | 180 | 0.180 |
Why?
|
| Bone Remodeling | 3 | 2014 | 569 | 0.180 |
Why?
|
| Regeneration | 2 | 2020 | 1486 | 0.180 |
Why?
|
| Amoxicillin | 5 | 2013 | 169 | 0.180 |
Why?
|
| Protein Kinase C | 4 | 2010 | 1227 | 0.180 |
Why?
|
| Receptors, GABA-B | 2 | 2016 | 68 | 0.180 |
Why?
|
| Periapical Tissue | 1 | 2019 | 10 | 0.170 |
Why?
|
| Microfilament Proteins | 2 | 2004 | 1152 | 0.170 |
Why?
|
| Obesity | 3 | 2017 | 12744 | 0.170 |
Why?
|
| Tetracycline | 5 | 2013 | 214 | 0.170 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 2 | 2016 | 108 | 0.170 |
Why?
|
| Salivary Proteins and Peptides | 2 | 2010 | 53 | 0.170 |
Why?
|
| Antibodies, Bacterial | 5 | 2005 | 1470 | 0.170 |
Why?
|
| Mandible | 3 | 2014 | 718 | 0.160 |
Why?
|
| NF-kappa B | 3 | 2022 | 2500 | 0.160 |
Why?
|
| Genetic Linkage | 1 | 2003 | 2419 | 0.160 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2016 | 1156 | 0.160 |
Why?
|
| Receptors, Death Domain | 1 | 2017 | 32 | 0.160 |
Why?
|
| Surgical Flaps | 4 | 2014 | 1629 | 0.150 |
Why?
|
| Dental Implantation, Endosseous | 2 | 2014 | 446 | 0.150 |
Why?
|
| Lung Neoplasms | 1 | 2022 | 13112 | 0.150 |
Why?
|
| Pain, Postoperative | 2 | 2005 | 1642 | 0.150 |
Why?
|
| Nutrition Surveys | 3 | 2021 | 1660 | 0.150 |
Why?
|
| Rats | 12 | 2023 | 24250 | 0.150 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 2 | 2009 | 99 | 0.150 |
Why?
|
| Absorbable Implants | 2 | 2010 | 336 | 0.150 |
Why?
|
| Dietary Supplements | 1 | 2010 | 3292 | 0.150 |
Why?
|
| Fibromyalgia | 1 | 2021 | 388 | 0.150 |
Why?
|
| Enzyme Activation | 4 | 2014 | 3701 | 0.150 |
Why?
|
| Acid Phosphatase | 3 | 2013 | 142 | 0.150 |
Why?
|
| Smoking | 10 | 2019 | 8984 | 0.140 |
Why?
|
| Nitric Oxide | 5 | 2016 | 2132 | 0.140 |
Why?
|
| Antigens, CD | 2 | 2021 | 4026 | 0.140 |
Why?
|
| Follow-Up Studies | 14 | 2013 | 39001 | 0.140 |
Why?
|
| Phosphatidate Phosphatase | 2 | 2021 | 21 | 0.140 |
Why?
|
| Osteoblasts | 3 | 2018 | 1164 | 0.140 |
Why?
|
| Cell Culture Techniques | 3 | 2013 | 1677 | 0.140 |
Why?
|
| Cisplatin | 1 | 2022 | 1662 | 0.140 |
Why?
|
| Interleukin-1alpha | 2 | 2013 | 85 | 0.130 |
Why?
|
| Program Development | 1 | 2002 | 1314 | 0.130 |
Why?
|
| Flavonoids | 3 | 2009 | 443 | 0.130 |
Why?
|
| Risk Factors | 15 | 2021 | 72252 | 0.130 |
Why?
|
| Data Interpretation, Statistical | 1 | 2005 | 2715 | 0.130 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 1 | 2015 | 103 | 0.130 |
Why?
|
| Collagen Type III | 1 | 2015 | 90 | 0.130 |
Why?
|
| Doxycycline | 2 | 2009 | 326 | 0.130 |
Why?
|
| Dental Cementum | 1 | 2014 | 52 | 0.130 |
Why?
|
| Fatty Acids | 1 | 2023 | 1809 | 0.130 |
Why?
|
| Molar, Third | 2 | 2005 | 48 | 0.120 |
Why?
|
| Toll-Like Receptor 4 | 4 | 2021 | 567 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2004 | 1284 | 0.120 |
Why?
|
| Toll-Like Receptor 2 | 4 | 2021 | 354 | 0.120 |
Why?
|
| Adiponectin | 1 | 2020 | 1101 | 0.120 |
Why?
|
| Root Canal Irrigants | 1 | 2014 | 15 | 0.120 |
Why?
|
| Light-Curing of Dental Adhesives | 1 | 2014 | 3 | 0.120 |
Why?
|
| Tooth, Nonvital | 1 | 2014 | 13 | 0.120 |
Why?
|
| Protein Isoforms | 2 | 2013 | 1729 | 0.120 |
Why?
|
| Dental Pulp Necrosis | 1 | 2014 | 21 | 0.120 |
Why?
|
| Pericoronitis | 1 | 2013 | 2 | 0.120 |
Why?
|
| Dental Calculus | 1 | 2013 | 12 | 0.120 |
Why?
|
| Dental Pulp Cavity | 1 | 2014 | 32 | 0.120 |
Why?
|
| Collagen Type I | 2 | 2015 | 592 | 0.120 |
Why?
|
| Caspases | 1 | 2017 | 928 | 0.120 |
Why?
|
| Th1 Cells | 2 | 2018 | 1057 | 0.120 |
Why?
|
| Aged | 17 | 2022 | 163178 | 0.120 |
Why?
|
| Periapical Diseases | 1 | 2013 | 20 | 0.120 |
Why?
|
| Osteotomy | 2 | 2011 | 820 | 0.120 |
Why?
|
| Blotting, Western | 4 | 2013 | 5179 | 0.120 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2015 | 155 | 0.120 |
Why?
|
| Lipid A | 1 | 2013 | 67 | 0.120 |
Why?
|
| Mice, Obese | 1 | 2014 | 426 | 0.120 |
Why?
|
| Glycoproteins | 1 | 2002 | 2266 | 0.120 |
Why?
|
| Cell Membrane | 2 | 2017 | 3749 | 0.120 |
Why?
|
| Adhesins, Bacterial | 2 | 2005 | 119 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 3 | 2016 | 6170 | 0.120 |
Why?
|
| 3T3 Cells | 1 | 2015 | 1102 | 0.120 |
Why?
|
| Analysis of Variance | 6 | 2012 | 6356 | 0.110 |
Why?
|
| Flow Cytometry | 4 | 2016 | 5973 | 0.110 |
Why?
|
| Myofibroblasts | 1 | 2015 | 222 | 0.110 |
Why?
|
| Collagen | 1 | 2022 | 2681 | 0.110 |
Why?
|
| Statistics, Nonparametric | 8 | 2012 | 2883 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2015 | 430 | 0.110 |
Why?
|
| Tooth Root | 1 | 2014 | 157 | 0.110 |
Why?
|
| Mouth, Edentulous | 1 | 2013 | 65 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-fos | 3 | 2006 | 575 | 0.110 |
Why?
|
| Concanavalin A | 1 | 2012 | 191 | 0.110 |
Why?
|
| Biomimetic Materials | 1 | 2014 | 179 | 0.110 |
Why?
|
| Cell Proliferation | 5 | 2016 | 10477 | 0.110 |
Why?
|
| Drug Combinations | 5 | 2013 | 1958 | 0.110 |
Why?
|
| Bone Marrow Cells | 1 | 2020 | 2509 | 0.110 |
Why?
|
| MAP Kinase Signaling System | 3 | 2004 | 1524 | 0.110 |
Why?
|
| RNA, Ribosomal, 16S | 3 | 2023 | 954 | 0.110 |
Why?
|
| Prostaglandins | 1 | 2013 | 405 | 0.110 |
Why?
|
| Finland | 1 | 2013 | 602 | 0.110 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2013 | 121 | 0.110 |
Why?
|
| Codon, Nonsense | 1 | 2013 | 281 | 0.110 |
Why?
|
| Epidemiologic Methods | 2 | 2007 | 1364 | 0.110 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2012 | 1800 | 0.110 |
Why?
|
| Intra-Abdominal Fat | 1 | 2017 | 591 | 0.110 |
Why?
|
| Microspectrophotometry | 1 | 2011 | 4 | 0.100 |
Why?
|
| Mucin-2 | 1 | 2012 | 49 | 0.100 |
Why?
|
| 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid | 1 | 2011 | 16 | 0.100 |
Why?
|
| Placebos | 2 | 2010 | 1674 | 0.100 |
Why?
|
| Hyperoxia | 1 | 2014 | 262 | 0.100 |
Why?
|
| Leukotrienes | 1 | 2013 | 255 | 0.100 |
Why?
|
| P-Selectin | 2 | 2011 | 601 | 0.100 |
Why?
|
| Connective Tissue | 1 | 2014 | 415 | 0.100 |
Why?
|
| Lipoproteins | 3 | 2013 | 881 | 0.100 |
Why?
|
| Calcimycin | 1 | 2011 | 222 | 0.100 |
Why?
|
| Radiopharmaceuticals | 2 | 2021 | 2647 | 0.100 |
Why?
|
| Diabetic Retinopathy | 1 | 2021 | 1211 | 0.100 |
Why?
|
| Analgesics, Opioid | 2 | 2005 | 3677 | 0.100 |
Why?
|
| Nanomedicine | 1 | 2014 | 302 | 0.100 |
Why?
|
| Ligands | 2 | 2017 | 3281 | 0.100 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2013 | 4749 | 0.100 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2013 | 431 | 0.100 |
Why?
|
| Molecular Typing | 1 | 2012 | 106 | 0.100 |
Why?
|
| Lactoferrin | 1 | 2012 | 97 | 0.100 |
Why?
|
| COS Cells | 1 | 2013 | 1161 | 0.100 |
Why?
|
| Glycosylation | 1 | 2014 | 1129 | 0.100 |
Why?
|
| Fatty Liver | 1 | 2017 | 728 | 0.100 |
Why?
|
| Cysteine Endopeptidases | 2 | 2005 | 563 | 0.100 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 644 | 0.100 |
Why?
|
| Dental Stress Analysis | 1 | 2011 | 60 | 0.100 |
Why?
|
| Nitric Oxide Synthase Type II | 2 | 2011 | 534 | 0.100 |
Why?
|
| Spectrophotometry | 2 | 2009 | 313 | 0.100 |
Why?
|
| Treatment Outcome | 11 | 2017 | 63042 | 0.100 |
Why?
|
| Blood Chemical Analysis | 1 | 2013 | 440 | 0.100 |
Why?
|
| NFATC Transcription Factors | 1 | 2013 | 381 | 0.100 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2015 | 710 | 0.100 |
Why?
|
| Amino Acid Motifs | 1 | 2013 | 936 | 0.100 |
Why?
|
| Glucose | 2 | 2017 | 4398 | 0.100 |
Why?
|
| Dendritic Cells | 4 | 2007 | 2720 | 0.090 |
Why?
|
| Down-Regulation | 4 | 2015 | 3000 | 0.090 |
Why?
|
| Salivary Glands | 1 | 2012 | 229 | 0.090 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2011 | 144 | 0.090 |
Why?
|
| Membrane Proteins | 4 | 2013 | 7880 | 0.090 |
Why?
|
| Toll-Like Receptors | 3 | 2009 | 593 | 0.090 |
Why?
|
| Alveoloplasty | 1 | 2009 | 22 | 0.090 |
Why?
|
| Dogs | 1 | 2015 | 3911 | 0.090 |
Why?
|
| Conserved Sequence | 1 | 2013 | 1202 | 0.090 |
Why?
|
| Actins | 2 | 2015 | 2121 | 0.090 |
Why?
|
| Receptor, Bradykinin B1 | 1 | 2009 | 10 | 0.090 |
Why?
|
| Dental Caries | 1 | 2013 | 414 | 0.090 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2016 | 1118 | 0.090 |
Why?
|
| Nanoparticles | 1 | 2021 | 1898 | 0.090 |
Why?
|
| Ferrous Compounds | 1 | 2009 | 42 | 0.090 |
Why?
|
| Maxilla | 2 | 2011 | 441 | 0.090 |
Why?
|
| Biopsy, Needle | 1 | 2015 | 1639 | 0.090 |
Why?
|
| Free Radical Scavengers | 1 | 2010 | 216 | 0.090 |
Why?
|
| Adolescent | 10 | 2021 | 85729 | 0.090 |
Why?
|
| Insulin Resistance | 1 | 2023 | 3863 | 0.090 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 1826 | 0.090 |
Why?
|
| Receptor Cross-Talk | 1 | 2009 | 118 | 0.090 |
Why?
|
| Gingival Recession | 2 | 2009 | 182 | 0.090 |
Why?
|
| Immunity, Humoral | 1 | 2014 | 598 | 0.090 |
Why?
|
| Cell Count | 2 | 2011 | 1855 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2015 | 1115 | 0.090 |
Why?
|
| Adenosine Diphosphate | 1 | 2010 | 425 | 0.090 |
Why?
|
| Interleukin-17 | 1 | 2015 | 902 | 0.090 |
Why?
|
| Porosity | 1 | 2010 | 360 | 0.090 |
Why?
|
| Receptors, Androgen | 1 | 2015 | 1055 | 0.080 |
Why?
|
| Lung Injury | 1 | 2014 | 432 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 3 | 2016 | 1602 | 0.080 |
Why?
|
| Interleukin-4 | 1 | 2012 | 1147 | 0.080 |
Why?
|
| Membrane Glycoproteins | 3 | 2005 | 3769 | 0.080 |
Why?
|
| Bacteria, Anaerobic | 1 | 2009 | 68 | 0.080 |
Why?
|
| Oxidants | 1 | 2009 | 164 | 0.080 |
Why?
|
| Peroxidase | 5 | 2015 | 611 | 0.080 |
Why?
|
| Imidazoles | 2 | 2005 | 1206 | 0.080 |
Why?
|
| Durapatite | 1 | 2009 | 159 | 0.080 |
Why?
|
| Polyesters | 1 | 2010 | 362 | 0.080 |
Why?
|
| Gene Expression | 5 | 2019 | 7793 | 0.080 |
Why?
|
| Leukocyte Count | 1 | 2012 | 1588 | 0.080 |
Why?
|
| Microscopy, Confocal | 3 | 2016 | 1962 | 0.080 |
Why?
|
| Housing | 1 | 2013 | 664 | 0.080 |
Why?
|
| Longitudinal Studies | 5 | 2013 | 13980 | 0.080 |
Why?
|
| Transfection | 2 | 2013 | 5892 | 0.080 |
Why?
|
| Control Groups | 1 | 2008 | 105 | 0.080 |
Why?
|
| Actinobacteria | 1 | 2008 | 56 | 0.080 |
Why?
|
| Pilot Projects | 6 | 2017 | 8316 | 0.080 |
Why?
|
| Immunity, Cellular | 1 | 2014 | 1608 | 0.080 |
Why?
|
| Age Factors | 6 | 2013 | 18355 | 0.080 |
Why?
|
| Reference Values | 1 | 2015 | 4974 | 0.080 |
Why?
|
| Exons | 1 | 2013 | 2438 | 0.080 |
Why?
|
| Gene Expression Regulation | 4 | 2021 | 12066 | 0.080 |
Why?
|
| Ferric Compounds | 1 | 2009 | 374 | 0.080 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2015 | 808 | 0.070 |
Why?
|
| Cell Migration Inhibition | 2 | 2004 | 96 | 0.070 |
Why?
|
| Materials Testing | 1 | 2011 | 866 | 0.070 |
Why?
|
| Stem Cells | 1 | 2020 | 3566 | 0.070 |
Why?
|
| Chlorhexidine | 2 | 2023 | 160 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2012 | 17439 | 0.070 |
Why?
|
| Debridement | 1 | 2009 | 492 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2013 | 4463 | 0.070 |
Why?
|
| Gene Expression Profiling | 3 | 2021 | 9440 | 0.070 |
Why?
|
| Lymphocytes | 2 | 2007 | 2615 | 0.070 |
Why?
|
| Single-Blind Method | 3 | 2013 | 1586 | 0.070 |
Why?
|
| Faculty, Dental | 2 | 2008 | 60 | 0.070 |
Why?
|
| Body Weight | 1 | 2017 | 4670 | 0.070 |
Why?
|
| Proteins | 1 | 2002 | 6098 | 0.070 |
Why?
|
| Chemokine CCL5 | 1 | 2007 | 209 | 0.070 |
Why?
|
| Platelet Activation | 1 | 2010 | 674 | 0.070 |
Why?
|
| Mouth | 2 | 2015 | 374 | 0.070 |
Why?
|
| Carbohydrate Metabolism | 1 | 2007 | 264 | 0.070 |
Why?
|
| DNA Probes | 1 | 2007 | 560 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 2 | 2018 | 6380 | 0.070 |
Why?
|
| Patient Compliance | 2 | 2008 | 2683 | 0.070 |
Why?
|
| Gene Targeting | 1 | 2010 | 879 | 0.070 |
Why?
|
| Molar | 2 | 2005 | 148 | 0.070 |
Why?
|
| Xerostomia | 1 | 2006 | 95 | 0.070 |
Why?
|
| S100 Proteins | 1 | 2006 | 259 | 0.070 |
Why?
|
| Reactive Oxygen Species | 3 | 2015 | 2077 | 0.070 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2017 | 1518 | 0.070 |
Why?
|
| Bone Transplantation | 1 | 2011 | 897 | 0.070 |
Why?
|
| B-Lymphocytes | 2 | 2009 | 4665 | 0.070 |
Why?
|
| Sample Size | 2 | 2008 | 841 | 0.070 |
Why?
|
| Densitometry | 1 | 2005 | 156 | 0.070 |
Why?
|
| Calcium-Binding Proteins | 2 | 2015 | 1081 | 0.070 |
Why?
|
| Stress, Mechanical | 1 | 2011 | 1684 | 0.070 |
Why?
|
| Cell Line | 5 | 2016 | 15993 | 0.070 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2006 | 821 | 0.070 |
Why?
|
| Immunoglobulin G | 4 | 2005 | 4561 | 0.070 |
Why?
|
| Mice, Knockout | 7 | 2023 | 14563 | 0.070 |
Why?
|
| Cyclic ADP-Ribose | 1 | 2005 | 17 | 0.070 |
Why?
|
| Enzyme Inhibitors | 5 | 2011 | 3794 | 0.060 |
Why?
|
| Mucositis | 1 | 2006 | 100 | 0.060 |
Why?
|
| Nitric Oxide Synthase | 2 | 2010 | 915 | 0.060 |
Why?
|
| Hydrocodone | 1 | 2005 | 47 | 0.060 |
Why?
|
| Cohort Studies | 4 | 2021 | 40545 | 0.060 |
Why?
|
| MicroRNAs | 1 | 2021 | 3750 | 0.060 |
Why?
|
| Chemotactic Factors | 1 | 2005 | 199 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2012 | 3917 | 0.060 |
Why?
|
| Histamine Antagonists | 1 | 2005 | 93 | 0.060 |
Why?
|
| Diltiazem | 1 | 2005 | 133 | 0.060 |
Why?
|
| Molecular Weight | 1 | 2007 | 2253 | 0.060 |
Why?
|
| Nifedipine | 1 | 2005 | 227 | 0.060 |
Why?
|
| Base Sequence | 3 | 2010 | 12798 | 0.060 |
Why?
|
| Verapamil | 1 | 2005 | 244 | 0.060 |
Why?
|
| Tooth Mobility | 1 | 2004 | 21 | 0.060 |
Why?
|
| Tosyl Compounds | 1 | 2005 | 113 | 0.060 |
Why?
|
| Hypertension | 4 | 2013 | 8480 | 0.060 |
Why?
|
| Gingivectomy | 1 | 2004 | 12 | 0.060 |
Why?
|
| Receptors, Lipoxin | 1 | 2005 | 84 | 0.060 |
Why?
|
| Mucous Membrane | 1 | 2008 | 669 | 0.060 |
Why?
|
| Tooth Bleaching | 1 | 2004 | 10 | 0.060 |
Why?
|
| Tooth Discoloration | 1 | 2004 | 15 | 0.060 |
Why?
|
| Hydrolases | 1 | 2005 | 139 | 0.060 |
Why?
|
| Prospective Studies | 5 | 2013 | 53250 | 0.060 |
Why?
|
| Receptors, Cell Surface | 2 | 2004 | 2865 | 0.060 |
Why?
|
| Platelet Count | 1 | 2007 | 780 | 0.060 |
Why?
|
| Osteonectin | 1 | 2004 | 34 | 0.060 |
Why?
|
| Receptors, CCR5 | 1 | 2006 | 498 | 0.060 |
Why?
|
| Lymphocyte Activation | 2 | 2012 | 5524 | 0.060 |
Why?
|
| Amidohydrolases | 1 | 2005 | 169 | 0.060 |
Why?
|
| Free Radicals | 1 | 2004 | 237 | 0.060 |
Why?
|
| Substance P | 1 | 2005 | 335 | 0.060 |
Why?
|
| Postmenopause | 1 | 2013 | 2458 | 0.060 |
Why?
|
| Chemotherapy, Adjuvant | 4 | 2012 | 3480 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2007 | 2556 | 0.060 |
Why?
|
| Dimethyl Sulfoxide | 1 | 2005 | 250 | 0.060 |
Why?
|
| Crown Lengthening | 1 | 2003 | 5 | 0.060 |
Why?
|
| Oxidation-Reduction | 1 | 2009 | 2183 | 0.060 |
Why?
|
| Sodium Fluoride | 1 | 2004 | 66 | 0.060 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2003 | 82 | 0.060 |
Why?
|
| GPI-Linked Proteins | 1 | 2005 | 435 | 0.060 |
Why?
|
| Half-Life | 1 | 2004 | 660 | 0.060 |
Why?
|
| Thrombosis | 1 | 2017 | 2968 | 0.060 |
Why?
|
| Polymers | 1 | 2011 | 1621 | 0.060 |
Why?
|
| Nerve Growth Factors | 1 | 2006 | 574 | 0.060 |
Why?
|
| Bone Density | 2 | 2014 | 3460 | 0.060 |
Why?
|
| Mouth Mucosa | 1 | 2006 | 432 | 0.060 |
Why?
|
| Complement C3-C5 Convertases | 1 | 2023 | 37 | 0.060 |
Why?
|
| Endothelial Cells | 1 | 2016 | 3482 | 0.060 |
Why?
|
| Chemokine CXCL1 | 1 | 2023 | 101 | 0.060 |
Why?
|
| Defensins | 1 | 2003 | 35 | 0.060 |
Why?
|
| Precipitin Tests | 1 | 2004 | 829 | 0.060 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2006 | 2503 | 0.060 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2003 | 144 | 0.060 |
Why?
|
| Mice, Mutant Strains | 1 | 2006 | 1862 | 0.060 |
Why?
|
| Epithelial Attachment | 1 | 2003 | 46 | 0.060 |
Why?
|
| Bacterial Typing Techniques | 1 | 2004 | 256 | 0.060 |
Why?
|
| Complement C3b | 1 | 2023 | 106 | 0.060 |
Why?
|
| Odds Ratio | 3 | 2006 | 9848 | 0.060 |
Why?
|
| Bacterial Load | 2 | 2013 | 153 | 0.060 |
Why?
|
| Cell Degranulation | 1 | 2003 | 287 | 0.050 |
Why?
|
| Esters | 1 | 2003 | 210 | 0.050 |
Why?
|
| Microspheres | 2 | 2002 | 777 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 8 | 2016 | 21824 | 0.050 |
Why?
|
| Peroxidases | 1 | 2003 | 138 | 0.050 |
Why?
|
| Comorbidity | 1 | 2017 | 10380 | 0.050 |
Why?
|
| Blood Glucose | 2 | 2014 | 6259 | 0.050 |
Why?
|
| Pyrimidinones | 1 | 2005 | 370 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2005 | 10940 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2021 | 8939 | 0.050 |
Why?
|
| Lipoxygenase | 1 | 2002 | 74 | 0.050 |
Why?
|
| Hemagglutinins | 1 | 2002 | 117 | 0.050 |
Why?
|
| Antigen-Presenting Cells | 1 | 2006 | 972 | 0.050 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 4777 | 0.050 |
Why?
|
| Time Factors | 6 | 2012 | 40038 | 0.050 |
Why?
|
| Fimbriae, Bacterial | 1 | 2002 | 138 | 0.050 |
Why?
|
| Protein Transport | 1 | 2008 | 1988 | 0.050 |
Why?
|
| Chemokines | 1 | 2006 | 968 | 0.050 |
Why?
|
| Eubacterium | 2 | 2013 | 23 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 2015 | 5021 | 0.050 |
Why?
|
| 20-Hydroxysteroid Dehydrogenases | 1 | 2021 | 6 | 0.050 |
Why?
|
| Stereoisomerism | 1 | 2003 | 624 | 0.050 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 329 | 0.050 |
Why?
|
| Matched-Pair Analysis | 1 | 2002 | 288 | 0.050 |
Why?
|
| Macrophage Colony-Stimulating Factor | 2 | 2013 | 193 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2006 | 792 | 0.050 |
Why?
|
| Blotting, Northern | 1 | 2003 | 1581 | 0.050 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2003 | 338 | 0.050 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2005 | 366 | 0.050 |
Why?
|
| Leukocyte Elastase | 1 | 2002 | 113 | 0.050 |
Why?
|
| Cattle | 1 | 2007 | 3917 | 0.050 |
Why?
|
| RNA, Bacterial | 1 | 2003 | 390 | 0.050 |
Why?
|
| Arachidonic Acids | 1 | 2002 | 299 | 0.050 |
Why?
|
| Prevotella | 2 | 2013 | 79 | 0.050 |
Why?
|
| Organizational Case Studies | 1 | 2002 | 299 | 0.050 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2002 | 163 | 0.050 |
Why?
|
| Brachial Artery | 1 | 2003 | 369 | 0.050 |
Why?
|
| Growth Substances | 1 | 2004 | 784 | 0.050 |
Why?
|
| Schools, Dental | 1 | 2002 | 122 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 11360 | 0.050 |
Why?
|
| Point Mutation | 1 | 2006 | 1623 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2023 | 2504 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2014 | 4033 | 0.050 |
Why?
|
| Interinstitutional Relations | 1 | 2002 | 240 | 0.050 |
Why?
|
| Bacteroides | 2 | 2013 | 161 | 0.050 |
Why?
|
| Cell Movement | 1 | 2013 | 5216 | 0.050 |
Why?
|
| Membrane Lipids | 1 | 2002 | 251 | 0.050 |
Why?
|
| DMF Index | 3 | 2006 | 90 | 0.050 |
Why?
|
| Diphosphonates | 1 | 2006 | 622 | 0.050 |
Why?
|
| Insulin | 1 | 2015 | 6584 | 0.050 |
Why?
|
| Acetaminophen | 1 | 2005 | 545 | 0.050 |
Why?
|
| Macrophage Activation | 1 | 2004 | 559 | 0.050 |
Why?
|
| Periodontal Debridement | 1 | 2020 | 8 | 0.050 |
Why?
|
| Structure-Activity Relationship | 1 | 2006 | 3128 | 0.050 |
Why?
|
| Blood Platelets | 1 | 2011 | 2509 | 0.050 |
Why?
|
| Alkaline Phosphatase | 1 | 2004 | 866 | 0.050 |
Why?
|
| Area Under Curve | 1 | 2004 | 1654 | 0.050 |
Why?
|
| Graft Survival | 1 | 2011 | 3734 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2002 | 1374 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2004 | 730 | 0.050 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2002 | 232 | 0.050 |
Why?
|
| Combined Modality Therapy | 2 | 2010 | 8637 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2023 | 2938 | 0.040 |
Why?
|
| Fibronectins | 1 | 2004 | 726 | 0.040 |
Why?
|
| Models, Immunological | 1 | 2002 | 527 | 0.040 |
Why?
|
| Amino Acid Sequence | 3 | 2007 | 13809 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 893 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2005 | 2029 | 0.040 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 2378 | 0.040 |
Why?
|
| Aging | 2 | 2008 | 8655 | 0.040 |
Why?
|
| Receptors, Cannabinoid | 1 | 2019 | 44 | 0.040 |
Why?
|
| Root Canal Therapy | 1 | 2019 | 57 | 0.040 |
Why?
|
| Vasodilation | 1 | 2003 | 944 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2007 | 18107 | 0.040 |
Why?
|
| Th2 Cells | 1 | 2004 | 1061 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2002 | 507 | 0.040 |
Why?
|
| Virulence | 1 | 2003 | 1328 | 0.040 |
Why?
|
| Community Health Services | 3 | 2009 | 650 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2003 | 1552 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2003 | 796 | 0.040 |
Why?
|
| Postoperative Complications | 1 | 2021 | 15281 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2013 | 12718 | 0.040 |
Why?
|
| Bone Density Conservation Agents | 1 | 2006 | 768 | 0.040 |
Why?
|
| Dental Pulp | 1 | 2019 | 82 | 0.040 |
Why?
|
| Cricetulus | 2 | 2010 | 818 | 0.040 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2020 | 2916 | 0.040 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2003 | 985 | 0.040 |
Why?
|
| Disease Progression | 2 | 2013 | 13273 | 0.040 |
Why?
|
| Interleukin-12 | 3 | 2006 | 577 | 0.040 |
Why?
|
| Research Support as Topic | 1 | 2002 | 705 | 0.040 |
Why?
|
| Germany | 1 | 2020 | 862 | 0.040 |
Why?
|
| Thiazoles | 1 | 2005 | 1482 | 0.040 |
Why?
|
| Health Status | 2 | 2008 | 4031 | 0.040 |
Why?
|
| Myocardium | 1 | 2010 | 4775 | 0.040 |
Why?
|
| CHO Cells | 2 | 2010 | 1409 | 0.040 |
Why?
|
| Haplotypes | 1 | 2003 | 2779 | 0.040 |
Why?
|
| Genotype | 1 | 2012 | 12944 | 0.040 |
Why?
|
| Immune Tolerance | 1 | 2006 | 2258 | 0.040 |
Why?
|
| Safety | 1 | 2002 | 1184 | 0.040 |
Why?
|
| DNA Replication | 1 | 2004 | 1399 | 0.040 |
Why?
|
| Peptides | 2 | 2009 | 4406 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2003 | 3585 | 0.030 |
Why?
|
| Receptor, Macrophage Colony-Stimulating Factor | 1 | 2016 | 89 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2004 | 1986 | 0.030 |
Why?
|
| Cricetinae | 2 | 2010 | 2475 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 16674 | 0.030 |
Why?
|
| Logistic Models | 3 | 2009 | 13404 | 0.030 |
Why?
|
| Acute Disease | 1 | 2006 | 7150 | 0.030 |
Why?
|
| Subgingival Curettage | 2 | 2008 | 10 | 0.030 |
Why?
|
| Androstenediol | 1 | 2015 | 3 | 0.030 |
Why?
|
| Young Adult | 4 | 2010 | 56392 | 0.030 |
Why?
|
| Brazil | 1 | 2020 | 1264 | 0.030 |
Why?
|
| International Cooperation | 1 | 2002 | 1419 | 0.030 |
Why?
|
| Aorta | 1 | 2003 | 2062 | 0.030 |
Why?
|
| Protein Kinases | 1 | 2003 | 1640 | 0.030 |
Why?
|
| Drug Hypersensitivity | 1 | 2004 | 884 | 0.030 |
Why?
|
| Patient Selection | 1 | 2008 | 4210 | 0.030 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2003 | 1030 | 0.030 |
Why?
|
| Testosterone | 2 | 2015 | 2297 | 0.030 |
Why?
|
| Arachidonate 12-Lipoxygenase | 1 | 2015 | 80 | 0.030 |
Why?
|
| Dietary Fats | 1 | 2003 | 2016 | 0.030 |
Why?
|
| Flutamide | 1 | 2015 | 96 | 0.030 |
Why?
|
| Dental Care | 2 | 2008 | 261 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2002 | 2369 | 0.030 |
Why?
|
| Minerals | 1 | 2016 | 267 | 0.030 |
Why?
|
| Osteoporosis | 1 | 2005 | 1577 | 0.030 |
Why?
|
| Glutamate Decarboxylase | 1 | 2016 | 246 | 0.030 |
Why?
|
| Androgen Receptor Antagonists | 1 | 2015 | 114 | 0.030 |
Why?
|
| Gram-Negative Bacteria | 2 | 2009 | 271 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2016 | 418 | 0.030 |
Why?
|
| Dihydrotestosterone | 1 | 2015 | 185 | 0.030 |
Why?
|
| Kidney | 1 | 2010 | 7185 | 0.030 |
Why?
|
| Pulpectomy | 1 | 2014 | 3 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2019 | 873 | 0.030 |
Why?
|
| Vascular Diseases | 1 | 2003 | 1161 | 0.030 |
Why?
|
| Tooth Calcification | 1 | 2014 | 8 | 0.030 |
Why?
|
| Biological Availability | 1 | 2015 | 397 | 0.030 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2019 | 850 | 0.030 |
Why?
|
| Sodium Hypochlorite | 1 | 2014 | 30 | 0.030 |
Why?
|
| Odontogenesis | 1 | 2014 | 66 | 0.030 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 25032 | 0.030 |
Why?
|
| Receptors, GABA | 1 | 2016 | 287 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 3874 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2016 | 465 | 0.030 |
Why?
|
| Biota | 1 | 2013 | 22 | 0.030 |
Why?
|
| Chemokine CCL3 | 1 | 2013 | 84 | 0.030 |
Why?
|
| Waist-Hip Ratio | 1 | 2015 | 516 | 0.030 |
Why?
|
| Chemokine CCL4 | 1 | 2013 | 129 | 0.030 |
Why?
|
| Treponema denticola | 1 | 2013 | 13 | 0.030 |
Why?
|
| Capnocytophaga | 1 | 2013 | 26 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2015 | 23327 | 0.030 |
Why?
|
| Fusobacterium | 1 | 2013 | 54 | 0.030 |
Why?
|
| Orchiectomy | 1 | 2015 | 468 | 0.030 |
Why?
|
| Research Design | 2 | 2008 | 5983 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 2009 | 0.030 |
Why?
|
| Pyridines | 1 | 2005 | 2827 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2015 | 906 | 0.030 |
Why?
|
| Streptococcus | 1 | 2013 | 197 | 0.030 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2016 | 664 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2013 | 57744 | 0.030 |
Why?
|
| beta-N-Acetylhexosaminidases | 2 | 2002 | 53 | 0.030 |
Why?
|
| Peritoneal Cavity | 1 | 2012 | 148 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2006 | 4152 | 0.030 |
Why?
|
| Cell Fusion | 1 | 2013 | 297 | 0.030 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2015 | 546 | 0.030 |
Why?
|
| Cathepsin D | 2 | 2002 | 61 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2003 | 4326 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2008 | 4687 | 0.030 |
Why?
|
| Secretory Rate | 1 | 2012 | 82 | 0.030 |
Why?
|
| Chemokine CXCL10 | 1 | 2013 | 305 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2016 | 627 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2015 | 8300 | 0.030 |
Why?
|
| Limit of Detection | 1 | 2013 | 265 | 0.030 |
Why?
|
| Time-Lapse Imaging | 1 | 2013 | 195 | 0.030 |
Why?
|
| Alleles | 1 | 2003 | 6934 | 0.030 |
Why?
|
| Immunoblotting | 1 | 2015 | 1683 | 0.030 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2013 | 297 | 0.030 |
Why?
|
| Ciprofloxacin | 1 | 2014 | 314 | 0.030 |
Why?
|
| Cellulose | 1 | 2012 | 121 | 0.030 |
Why?
|
| Dipeptides | 2 | 2004 | 409 | 0.030 |
Why?
|
| Integrin-Binding Sialoprotein | 1 | 2011 | 23 | 0.030 |
Why?
|
| Interleukin-6 | 2 | 2015 | 3208 | 0.020 |
Why?
|
| Receptors, Calcitonin | 1 | 2011 | 37 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2016 | 1880 | 0.020 |
Why?
|
| Cathepsin K | 1 | 2011 | 67 | 0.020 |
Why?
|
| Pulmonary Alveoli | 1 | 2014 | 674 | 0.020 |
Why?
|
| Receptors, CXCR4 | 1 | 2016 | 727 | 0.020 |
Why?
|
| Age of Onset | 2 | 2010 | 3268 | 0.020 |
Why?
|
| Thiobarbituric Acid Reactive Substances | 1 | 2010 | 46 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2006 | 6078 | 0.020 |
Why?
|
| Epithelial Cells | 1 | 2003 | 3690 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2016 | 2086 | 0.020 |
Why?
|
| Osteocalcin | 1 | 2011 | 273 | 0.020 |
Why?
|
| Prevalence | 3 | 2019 | 15211 | 0.020 |
Why?
|
| Cell Separation | 1 | 2016 | 1750 | 0.020 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2010 | 254 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2023 | 3645 | 0.020 |
Why?
|
| Guanidines | 1 | 2011 | 193 | 0.020 |
Why?
|
| Protein Subunits | 2 | 2004 | 959 | 0.020 |
Why?
|
| Skin | 1 | 2003 | 4372 | 0.020 |
Why?
|
| Selenomonas | 1 | 2009 | 11 | 0.020 |
Why?
|
| Eikenella corrodens | 1 | 2009 | 18 | 0.020 |
Why?
|
| Treponema | 1 | 2009 | 38 | 0.020 |
Why?
|
| Peptostreptococcus | 1 | 2009 | 27 | 0.020 |
Why?
|
| Campylobacter | 1 | 2009 | 59 | 0.020 |
Why?
|
| Receptors, Purinergic P2Y12 | 1 | 2010 | 132 | 0.020 |
Why?
|
| Proteobacteria | 1 | 2009 | 45 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2005 | 7908 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2005 | 4245 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 2 | 2013 | 5867 | 0.020 |
Why?
|
| Bacteroidetes | 1 | 2009 | 83 | 0.020 |
Why?
|
| Osteopontin | 1 | 2011 | 294 | 0.020 |
Why?
|
| Receptors, Purinergic P2 | 1 | 2010 | 153 | 0.020 |
Why?
|
| Escherichia coli | 3 | 2008 | 4216 | 0.020 |
Why?
|
| Bradykinin | 1 | 2009 | 214 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 1351 | 0.020 |
Why?
|
| Dental Instruments | 1 | 2008 | 15 | 0.020 |
Why?
|
| Anthraquinones | 1 | 2008 | 37 | 0.020 |
Why?
|
| Fibrosis | 1 | 2015 | 2030 | 0.020 |
Why?
|
| Spleen | 2 | 2006 | 2359 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2006 | 10179 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2021 | 10251 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2014 | 2725 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2005 | 5532 | 0.020 |
Why?
|
| Gram-Positive Bacteria | 1 | 2009 | 185 | 0.020 |
Why?
|
| Sex Factors | 3 | 2010 | 10394 | 0.020 |
Why?
|
| Fluoresceins | 1 | 2008 | 235 | 0.020 |
Why?
|
| Periodicals as Topic | 2 | 2009 | 1429 | 0.020 |
Why?
|
| Cardiology | 2 | 2009 | 1668 | 0.020 |
Why?
|
| Feasibility Studies | 2 | 2008 | 5078 | 0.020 |
Why?
|
| Estradiol | 1 | 2015 | 2017 | 0.020 |
Why?
|
| Tooth Diseases | 1 | 2008 | 77 | 0.020 |
Why?
|
| Air | 1 | 2008 | 182 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2016 | 2969 | 0.020 |
Why?
|
| United States | 5 | 2009 | 69859 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2005 | 19894 | 0.020 |
Why?
|
| Pancreatic Elastase | 1 | 2007 | 136 | 0.020 |
Why?
|
| Transforming Growth Factor beta | 2 | 2006 | 2006 | 0.020 |
Why?
|
| Sympathomimetics | 1 | 2006 | 57 | 0.020 |
Why?
|
| Students, Dental | 1 | 2008 | 159 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2016 | 1978 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2009 | 765 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2009 | 391 | 0.020 |
Why?
|
| Histamine H1 Antagonists | 1 | 2006 | 100 | 0.020 |
Why?
|
| Tyrosine | 1 | 2010 | 1462 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2016 | 9272 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 2891 | 0.020 |
Why?
|
| Opsonin Proteins | 1 | 2005 | 150 | 0.020 |
Why?
|
| Foot | 1 | 2009 | 527 | 0.020 |
Why?
|
| Antigen-Antibody Complex | 1 | 2007 | 517 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 3503 | 0.020 |
Why?
|
| Bicuspid | 1 | 2005 | 71 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 971 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2004 | 3772 | 0.020 |
Why?
|
| Edema | 1 | 2009 | 789 | 0.020 |
Why?
|
| Yeasts | 1 | 2006 | 284 | 0.020 |
Why?
|
| MAP Kinase Kinase 3 | 1 | 2004 | 25 | 0.020 |
Why?
|
| MAP Kinase Kinase 6 | 1 | 2004 | 25 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2013 | 3205 | 0.020 |
Why?
|
| Tooth Loss | 1 | 2006 | 196 | 0.010 |
Why?
|
| Abscess | 1 | 2008 | 607 | 0.010 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2003 | 50 | 0.010 |
Why?
|
| Antigens, Helminth | 1 | 2003 | 64 | 0.010 |
Why?
|
| Toll-Like Receptor 5 | 1 | 2003 | 39 | 0.010 |
Why?
|
| Genes, Immediate-Early | 1 | 2004 | 101 | 0.010 |
Why?
|
| Community-Acquired Infections | 1 | 2008 | 465 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2003 | 77 | 0.010 |
Why?
|
| Tooth Preparation, Prosthodontic | 1 | 2003 | 13 | 0.010 |
Why?
|
| Receptors, IgG | 1 | 2007 | 581 | 0.010 |
Why?
|
| Cholesterol, HDL | 1 | 2010 | 1813 | 0.010 |
Why?
|
| Radiography, Bitewing | 1 | 2003 | 34 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2004 | 475 | 0.010 |
Why?
|
| Skull | 1 | 2008 | 812 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 9944 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2003 | 251 | 0.010 |
Why?
|
| Amoxicillin-Potassium Clavulanate Combination | 1 | 2003 | 30 | 0.010 |
Why?
|
| Protein Phosphatase 1 | 1 | 2003 | 137 | 0.010 |
Why?
|
| Flagellin | 1 | 2003 | 125 | 0.010 |
Why?
|
| Dental Prophylaxis | 1 | 2002 | 26 | 0.010 |
Why?
|
| Colony Count, Microbial | 1 | 2003 | 331 | 0.010 |
Why?
|
| p21-Activated Kinases | 1 | 2003 | 128 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 2004 | 494 | 0.010 |
Why?
|
| Threonine | 1 | 2003 | 279 | 0.010 |
Why?
|
| Helminth Proteins | 1 | 2003 | 171 | 0.010 |
Why?
|
| Lectins, C-Type | 1 | 2006 | 589 | 0.010 |
Why?
|
| Retrospective Studies | 4 | 2021 | 77410 | 0.010 |
Why?
|
| Crowns | 1 | 2003 | 144 | 0.010 |
Why?
|
| Triglycerides | 1 | 2010 | 2453 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2008 | 2718 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2015 | 3965 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2009 | 1529 | 0.010 |
Why?
|
| Ovalbumin | 1 | 2004 | 719 | 0.010 |
Why?
|
| Sirolimus | 1 | 2009 | 1565 | 0.010 |
Why?
|
| Nitroglycerin | 1 | 2003 | 325 | 0.010 |
Why?
|
| Observer Variation | 1 | 2008 | 2592 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2009 | 1950 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 2003 | 1386 | 0.010 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2004 | 599 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2004 | 646 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 595 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2004 | 625 | 0.010 |
Why?
|
| Cholesterol | 1 | 2010 | 2922 | 0.010 |
Why?
|
| Glucuronidase | 1 | 2002 | 207 | 0.010 |
Why?
|
| Antigens, Differentiation | 1 | 2004 | 927 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 2002 | 577 | 0.010 |
Why?
|
| Epidermal Growth Factor | 1 | 2004 | 709 | 0.010 |
Why?
|
| Protein Binding | 1 | 2013 | 9377 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 2217 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2010 | 6620 | 0.010 |
Why?
|
| Psychotropic Drugs | 1 | 2006 | 893 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2008 | 1903 | 0.010 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2004 | 880 | 0.010 |
Why?
|
| Cardiovascular Agents | 1 | 2006 | 850 | 0.010 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2004 | 571 | 0.010 |
Why?
|
| Serine | 1 | 2003 | 825 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2003 | 1369 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 2003 | 1525 | 0.010 |
Why?
|
| Radiography | 1 | 2010 | 7010 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2003 | 974 | 0.010 |
Why?
|
| Phenotype | 1 | 2016 | 16361 | 0.010 |
Why?
|
| Lung | 1 | 2015 | 9858 | 0.010 |
Why?
|
| Lysosomes | 1 | 2002 | 893 | 0.010 |
Why?
|
| Heart | 1 | 2010 | 4460 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2003 | 1870 | 0.010 |
Why?
|
| Pneumonia | 1 | 2008 | 2133 | 0.010 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2004 | 2453 | 0.010 |
Why?
|
| Blood Pressure | 1 | 2010 | 8551 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 2914 | 0.010 |
Why?
|
| Linear Models | 1 | 2004 | 5952 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2008 | 14714 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 15526 | 0.010 |
Why?
|
| Veterans | 1 | 2006 | 2519 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2003 | 6487 | 0.010 |
Why?
|
| Infant | 2 | 2004 | 35122 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2004 | 40964 | 0.010 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2004 | 4386 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 29777 | 0.010 |
Why?
|
| Recurrence | 1 | 2002 | 8337 | 0.010 |
Why?
|
| Depression | 1 | 2008 | 7760 | 0.000 |
Why?
|
| Child | 2 | 2004 | 77637 | 0.000 |
Why?
|
| Prognosis | 1 | 2006 | 29052 | 0.000 |
Why?
|